Lilly’s Cyramza closer to first-line lung cancer use after ODAC verdictEli Lilly’s cancer drug Cyramza has inched closer to a new indication in first-line non-small cell lung cancer Share XLilly’s Cyramza closer to first-line lung cancer use after ODAC verdicthttps://pharmaphorum.com/news/lilly-closes-on-first-line-lung-cancer-use-after-odac-verdict/
Takeda buys US biotech PvP Biologics for $330 millionTakeda has bought US biotech PvP Biologics for $330 million, adding a potential new form of therapy for Share XTakeda buys US biotech PvP Biologics for $330 millionhttps://pharmaphorum.com/news/takeda-buys-us-biotech-pvp-biologics-for-330-million/
Google, Amazon and Microsoft give input to new health AI standardThe US-based Consumer Technology Association (CTA) has developed the first ever accredited standard for use of artificial intelligence Share XGoogle, Amazon and Microsoft give input to new health AI standardhttps://pharmaphorum.com/news/google-and-microsoft-give-input-to-new-healthcare-ai-standard/
Building the foundations of digital health literacyFrom policy to grassroots levels, there’s a heavy emphasis on the value of digital health throughout healthcare systems. Share XBuilding the foundations of digital health literacyhttps://pharmaphorum.com/views-analysis-digital/building-foundations-digital-health-literacy/
UCB’s James Musick on embracing digital therapeuticsDigital has rapidly taken over the pharma industry, but many still don’t fully understand how to harness it. Share XUCB’s James Musick on embracing digital therapeuticshttps://pharmaphorum.com/views-analysis-digital/ucbs-james-musick-on-embracing-digital-therapeutics/
Listen and support: How to conduct a patient-centric clinical studyClinical trial sponsors understand the value of patient-centric studies, but success relies on a time-consuming paradigm shift and Share XListen and support: How to conduct a patient-centric clinical studyhttps://pharmaphorum.com/r-d/views-analysis-r-d/listen-and-support-how-to-conduct-a-patient-centric-clinical-study/
Deep Dive: R&D DisruptionWith costs skyrocketing and return on investment plummeting, R&D arguably needs disruption more than any other area of Share XDeep Dive: R&D Disruptionhttps://pharmaphorum.com/r-d/views-analysis-r-d/deep-dive-rd-disruption/
True pharma-patient co-creationA recent MS patient group forum hosted by Merck KGaA demonstrates the power of true co-creation with patients. Share XTrue pharma-patient co-creationhttps://deep-dive.pharmaphorum.com/magazine/patient-engagement/true-pharma-patient-co-creation-merck-ms/
Learning from online patient peer support groupsOnline patient communities have become a staple part of the healthcare landscape in recent years, presenting the sector Share XLearning from online patient peer support groupshttps://deep-dive.pharmaphorum.com/magazine/patient-engagement/learning-from-online-patient-peer-support-groups/
How ‘thinking modular’ might ease digital content overload in pharma Share XHow ‘thinking modular’ might ease digital content overload in pharmahttps://pharmaphorum.com/sales-marketing/how-thinking-modular-might-ease-digital-content-overload-in-pharma/
Applying behavioural interventions in chronic diseases Share XApplying behavioural interventions in chronic diseaseshttps://pharmaphorum.com/sales-marketing/applying-behavioural-interventions-in-chronic-diseases/
Informed patients: evolving healthcare, clinical trials and medical information Share XInformed patients: evolving healthcare, clinical trials and medical informationhttps://pharmaphorum.com/sales-marketing/informed-patients-evolving-healthcare-clinical-trials-and-medical-information/
5 big challenges for pharmaceutical marketers (and their agencies)For the patient demanding access to the latest medicine or the healthcare professional desperate to be able to Share X5 big challenges for pharmaceutical marketers (and their agencies)https://pharmaphorum.com/whitepapers/5-big-challenges-for-pharmaceutical-marketers-and-their-agencies/
How pharma companies can uncover the insights hidden in their contentFrom multichannel distribution to customer engagement to creative collaboration and beyond, the pharmaceutical industry is evolving the way Share XHow pharma companies can uncover the insights hidden in their contenthttps://pharmaphorum.com/whitepapers/how-pharma-companies-can-uncover-the-insights-hidden-in-their-content/
What is the state of healthcare customer data in pharma? Have your sayHealthcare customer reference data is the fuel that powers pharmaceutical commercial operations. But does the life sciences industry Share XWhat is the state of healthcare customer data in pharma? Have your sayhttps://pharmaphorum.com/white-papers/what-is-the-state-of-healthcare-customer-data-in-pharma-have-your-say/
Sanofi’s Bozidar Jovicevic on how the company is approaching digital therapeutics Share XSanofi’s Bozidar Jovicevic on how the company is approaching digital therapeuticshttps://pharmaphorum.com/video/sanofis-bozidar-jovicevic-on-how-the-company-is-approaching-digital-therapeutics/
UCB’s James Musick on embracing digital therapeutics Share XUCB’s James Musick on embracing digital therapeuticshttps://pharmaphorum.com/views-analysis-digital/ucbs-james-musick-on-embracing-digital-therapeutics/
Millendo’s Julia Owens on leadership in rare diseases Share XMillendo’s Julia Owens on leadership in rare diseaseshttps://pharmaphorum.com/r-d/views-analysis-r-d/millendo-julia-owens-leadership-rare-diseases/
Key Questions To Boost Your KOL Management– Part 2/8: KOL Mapping Share XKey Questions To Boost Your KOL Management– Part 2/8: KOL Mappinghttps://pharmaphorum.com/partner-content/key-questions-to-boost-your-kol-management-part-2-8-kol-mapping/
Redefining DTC Advertising: Capitalizing on a multi-dimensional, largely digital experience Share XRedefining DTC Advertising: Capitalizing on a multi-dimensional, largely digital experiencehttps://pharmaphorum.com/partner-content/redefining-dtc-advertising-capitalizing-on-a-multi-dimensional-largely-digital-experience/
Interview with Chair Lynne Ensor at Microbiology Boston Conference, speaks about Coronavirus Share XInterview with Chair Lynne Ensor at Microbiology Boston Conference, speaks about Coronavirushttps://pharmaphorum.com/partner-content/interview-with-chair-lynne-ensor-at-microbiology-boston-conference-speaks-about-coronavirus/
Exclusive Interview with Martin Everett, CSO, Antabio, speaking at Superbugs & Superdrugs Share XExclusive Interview with Martin Everett, CSO, Antabio, speaking at Superbugs & Superdrugshttps://pharmaphorum.com/partner-content/exclusive-interview-with-martin-everett-cso-antabio-speaking-at-superbugs-superdrugs/
Prescient hires senior members to Advisory Share XPrescient hires senior members to Advisoryhttps://pharmaphorum.com/partner-content/prescient-hires-senior-members-to-advisory/
Prescient Intelligence & Insight announces recent appointments to the senior team Share XPrescient Intelligence & Insight announces recent appointments to the senior teamhttps://pharmaphorum.com/partner-content/prescient-intelligence-insight-announces-recent-appointments-to-the-senior-team/
